Loading...
Medtronic plc
MDT•NYSE
HealthcareMedical - Devices
$87.38
$0.38(0.44%)
Medtronic plc (MDT) Financial Performance & Statements
Review Medtronic plc’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
3.64%
↑ 3.64%
Operating Income Growth
-6.22%
↓ 6.22%
Net Income Growth
-2.18%
↓ 2.18%
Operating Cash Flow Growth
12.39%
↑ 12.39%
Operating Margin
18.21%
↑ 18.21%
Gross Margin
62.89%
↑ 62.89%
Net Profit Margin
12.83%
↑ 12.83%
ROE
8.69%
↑ 8.69%
ROIC
7.74%
↑ 7.74%
Medtronic plc (MDT) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Medtronic plc stock.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $8.29B | $8.40B | $7.92B | $8.59B |
| Cost of Revenue | $2.78B | $2.95B | $3.20B | $3.39B |
| Gross Profit | $5.51B | $5.46B | $4.71B | $5.20B |
| Gross Profit Ratio | $0.66 | $0.65 | $0.60 | $0.61 |
| R&D Expenses | $675.00M | $697.00M | $676.00M | $675.00M |
| SG&A Expenses | $2.72B | $2.76B | $2.63B | $2.73B |
| Operating Expenses | $3.87B | $3.86B | $3.88B | $3.67B |
| Total Costs & Expenses | $6.65B | $6.81B | $6.64B | $7.06B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $179.00M | $209.00M | $167.00M | $202.00M |
| Depreciation & Amortization | $684.00M | $675.00M | $662.00M | $654.00M |
| EBITDA | $2.40B | $2.44B | $2.05B | $2.50B |
| EBITDA Ratio | $0.29 | $0.29 | $0.26 | $0.29 |
| Operating Income | $1.65B | $1.59B | $1.28B | $1.53B |
| Operating Income Ratio | $0.20 | $0.19 | $0.16 | $0.18 |
| Other Income/Expenses (Net) | -$106.00M | -$36.00M | -$10.00M | -$197.00M |
| Income Before Tax | $1.54B | $1.56B | $1.27B | $856.00M |
| Income Before Tax Ratio | $0.19 | $0.19 | $0.16 | $0.10 |
| Income Tax Expense | $237.00M | $281.00M | $220.00M | $196.00M |
| Net Income | $1.29B | $1.27B | $1.04B | $654.00M |
| Net Income Ratio | $0.16 | $0.15 | $0.13 | $0.08 |
| EPS | $1.01 | $0.99 | $0.81 | $0.49 |
| Diluted EPS | $1.01 | $0.99 | $0.80 | $0.49 |
| Weighted Avg Shares Outstanding | $1.28B | $1.28B | $1.29B | $1.32B |
| Weighted Avg Shares Outstanding (Diluted) | $1.29B | $1.29B | $1.30B | $1.33B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan